AGRAWAL S ET AL: "Clinical pharmacokinetics (PK) of BMS-936558, a fully human anti-PD-1 monoclonal antibody", JOURNAL OF CLINICAL ONCOLOGY; 2012 ASCO ANNUAL MEETING, AMERICAN SOCIETY OF CLINICAL ONCOLOGY, US , vol. 30, no. suppl 2012, page 1, XP002734393, ISSN: 0732-183X Retrieved from the Internet: URL:http://meetinglibrary.asco.org/content /98623-114 [retrieved on 2015-01-13] (B1)

BRISTOL-MYERS SQUIBB: "View of NCT01968109 on 2014_06_20; Safety Study of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors", INTERNET CITATION, 20 June 2014 (2014-06-20), pages 1-4, XP002734391, Retrieved from the Internet: URL:https://clinicaltrials.gov/archive/NCT 01968109/2014_06_20 [retrieved on 2015-01-13] (B1)

BRISTOL-MYERS SQUIBB: "View of NCT02061761 on 2014_08_28; Safety Study of Anti-LAG-3 in CLL, HL and NHL", INTERNET CITATION, 28 August 2014 (2014-08-28), pages 1-4, XP002734392, Retrieved from the Internet: URL:https://clinicaltrials.gov/archive/NCT 02061761/2014_08_28 [retrieved on 2015-01-13] (B1)

JEDD D. WOLCHOK ET AL: "Nivolumab plus Ipilimumab in Advanced Melanoma", NEW ENGLAND JOURNAL OF MEDICINE, vol. 369, no. 2, 11 July 2013 (2013-07-11) , pages 122-133, XP055182024, ISSN: 0028-4793, DOI: 10.1056/NEJMoa1302369 (B1)

WO-A2-2010/019570 (B1)

STEPHEN R GODING ET AL: "Combination of adoptive cell transfer, anti-PD-L1 and anti-LAG-3 antibodies for the treatment of recurrent tumors Better with more", ONCOIMMUNOLOGY, LANDES BIOSCIENCE, US, vol. 2, no. 8, 22 October 2013 (2013-10-22), pages e25050-1, XP002734389, ISSN: 2162-4011, DOI: 10.4161/ONCI.25050 [retrieved on 2013-05-20] (B1)

TURNIS M E ET AL: "Combinatorial Immunotherapy: PD-1 may not be LAG-ing behind any more", ONCOIMMUNOLOGY, LANDES BIOSCIENCE, US, vol. 1, no. 7, 1 October 2012 (2012-10-01) , pages 1172-1174, XP002734390, ISSN: 2162-4011, DOI: 10.4161/ONCI.20593 (B1)

WO-A1-2014/008218 (B1)

WO-A1-2015/016718 (B1)

S.-R. WOO ET AL: "Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape", CANCER RESEARCH, vol. 72, no. 4, 20 December 2011 (2011-12-20), pages 917-927, XP055151722, ISSN: 0008-5472, DOI: 10.1158/0008-5472.CAN-11-1620 (B1)